VolitionRx is a clinical diagnostics company developing easy-to-use and cost-effective blood tests to diagnose a range of diseases in humans and animals including sepsis and cancer. Diagnostic Nu.Q tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid.
More VolitionRX content > View more
Sector |
|---|
|
Healthcare
Access more Healthcare content
|
Share price graph
Price performance
% |
1m |
3m |
12m |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||
| *% relative to local index | |||||||||||||||
Key management |
|
|---|---|
| Cameron Reynolds | CEO |
| Terig Hughes | CFO |
| Jake Micallef | Chief Scientific Officer |
| Scott Powell | Director of IR |